Related Experiment Video
Updated: Jan 31, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs
Ulrich H Weidle1, Alexandra Epp2, Fabian Birzele3
1Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany ulrich.brinkmann@roche.com weidle49@t-online.de.
Abstract:
The mortality of patients with hormone-resistant prostate cancer can be ascribed to a large degree to metastasis to distant organs, predominantly to the bones. In this review, we discuss the contribution of micro-RNAs (miRs) to the metastatic process of prostate cancer. The criteria for selection of miRs for this review were the availability of preclinical in vivo metastasis-related data in conjunction with prognostic clinical data. Depending on their function in the metastatic process, the corresponding miRs are up- or down-regulated in prostate cancer tissues when compared to matching normal tissues. Up-regulated miRs preferentially target suppressors of cytokine signaling or tumor suppressor-related genes and metastasis-inhibitory transcription factors. Down-regulated miRs promote epithelial-mesenchymal transition or mesenchymal-epithelial transition and diverse pro-metastatic signaling pathways. Some of the discussed miRs exert their function by simultaneously targeting epigenetic pathways as well as cell-cycle-related, anti-apoptotic and signaling-promoting targets. Finally, we discuss potential therapeutic options for the treatment of prostate cancer-related metastases by substitution or inhibition of miRs.
Insights
Micro-RNAs (miRs) significantly influence prostate cancer metastasis. This review details how specific miRs promote or inhibit cancer spread and explores their therapeutic potential for bone metastases.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer mortality is largely driven by bone metastasis.
- Micro-RNAs (miRs) are implicated in cancer progression and metastasis.
- Understanding miR roles is crucial for developing targeted therapies.
Purpose of the Study:
- To review the role of micro-RNAs (miRs) in prostate cancer metastasis.
- To correlate preclinical in vivo data with clinical prognostic data for miRs.
- To explore miR-based therapeutic strategies for prostate cancer bone metastases.
Main Methods:
- Literature review focusing on miRs with preclinical metastasis data and clinical prognostic data.
- Analysis of miR expression (up-regulation/down-regulation) in prostate cancer tissues versus normal tissues.
- Examination of miR targets, including signaling pathways, epigenetic regulators, and cell cycle genes.
Main Results:
- Specific miRs are up-regulated or down-regulated in prostate cancer, influencing metastasis.
- Up-regulated miRs often target tumor suppressors and metastasis inhibitors.
- Down-regulated miRs promote epithelial-mesenchymal transition and pro-metastatic signaling.
Conclusions:
- Micro-RNAs play a critical role in prostate cancer metastasis, particularly to bone.
- MiRs can target multiple pathways, including epigenetic and cell-cycle related genes.
- Therapeutic strategies involving miR substitution or inhibition show promise for treating metastases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Small interfering RNAs (siRNA)

